Industry Slants Drug Benefits in Presentations to MDs
May 23rd, 2012
In an era of evidence-based clinical care, a new study finds that research presented to psychiatrists during their annual ...
In an era of evidence-based clinical care, a new study finds that research presented to psychiatrists during their annual ...
People who suffer from an anxiety disorder in addition to bipolar disorder are more likely to have severe symptoms of bipolar, ...
Some individuals with bipolar disorder say they experience highly-valued, positive experiences from living with the condition, according to new research by Lancaster University.
According to the study, ten people (ages 24 to 57) ...
Emerging research suggests individuals with epilepsy have an increased risk of psychotic disorders including bipolar disease and schizophrenia.
In the study, Finnish researchers determined individuals with epilepsy ...
An international team of researchers have collaborated to identify genes that either protect or expose the brain's resistance to a variety of mental illnesses ...
The U.S. Food and Drug Administration (FDA) on Wednesday announced that it has approved generic versions of the atypical antipsychotic medication, Seroquel (quetiapine). Seroquel is commonly prescribed to ...
The growing number of psychiatric disorders, and subsequent labels assigned to patients, may make it harder for those patients to get the support they need.
According ...
Copyright © 1992-2012 Psych Central. All rights reserved.
Site last updated: 26 May 2012
|
